NICOLE LIM: Open Payments
NPI 1346562584 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 8 companies in 2025. Trend: 2023 $419 · 2024 $369 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: VRAYLAR, TRINTELLIX, FANAPT, Qelbree, REXULTI, CAPLYTA, INVEGA SUSTENNA, ARISTADA.
Industry payments across WV — which companies pay providers there.
